KAL1 Antikörper (Center)
Kurzübersicht für KAL1 Antikörper (Center) (ABIN783480)
Target
Alle KAL1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Center
-
Spezifität
- This antibody detects Anosmin (Center).
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human
-
Aufreinigung
- Affinity chromatography
-
Immunogen
- Raised against an 18 amino acid peptide near the center of human Anosmin
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- PBS containing 0.02 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C for longer.
-
-
- KAL1 (Kallmann Syndrome 1 Sequence (KAL1))
-
Andere Bezeichnung
- Anosmin-1
-
Hintergrund
- Mutations in Anosmin-1, an extracellular matrix-associated glycosylated protein, have been linked with Kallmann Syndrome (KS), an X-linked genetic disorder characterized by loss of smell caused by abnormal olfactory bulb development and delayed puberty caused by disrupted migration of the gonadotropin-releasing hormone neuron. Anosmin-1 has been shown to directly bind FGFR1 via its N-terminal cysteine-rich domain, whey-acidic protein-like domain, and its first FnIII repeat with the D2 and D3 ectodomains of FGFR1. It is thought that Anosmin-1 can modulate FGFR1 signaling and have opposing effects on the formation and activation of FGF2-FGFR1-heparing complex.Synonyms: ADMLX, Adhesion molecule-like X-linked, KAL, KAL1, KALIG1, Kallmann syndrome protein
-
Gen-ID
- 3730
-
NCBI Accession
- NP_000207
-
UniProt
- P23352
Target
-